Paydirt
Insider filing · ARQT

Todd Watanabe sold $1.5M of Arcutis Biotherapeutics (ARQT)

Executed Nov 24 2025, disclosed Nov 24 2025, the same day.

Value, as filed
$1.5M
48,945 sh × $30.36
Executed
Nov 24 2025
the trade date, as filed
Disclosed
Nov 24 2025
0 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only

Returns are measured on stock purchases only.

The filer
TW Todd Watanabe See Remarks profile →

Todd Watanabe (See Remarks) filed 7 Form 4 reports in the trailing twelve months (0 purchases, 7 sales), most often in Arcutis Biotherapeutics, Inc. (ARQT). The largest single filing was $1.5M of ARQT (48,945 sh × $30.36, as filed), executed Nov 24 2025.

The name
ARQT Arcutis Biotherapeutics, Inc. ARQT · Healthcare · 65 filings in 24 months ticker →

Healthcare · Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→
Other filings by Todd Watanabe in ARQT
ARQTSALE Arcutis Biotherapeutics, Inc. $114K
4,375 sh × $26.12
Exec Aug 3
Filed Aug 5 · 9:42 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. $913K
36,281 sh × $25.16
Exec Mar 2
Filed Mar 3 · 5:30 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. $506K
19,833 sh × $25.50
Exec Feb 2
Filed Feb 4 · 5:30 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. $284K
11,478 sh × $24.71
Exec Nov 3 2025
Filed Nov 5 2025 · 5:30 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. $1.0M
40,000 sh × $25.03
Exec Oct 28 2025
Filed Oct 30 2025 · 5:30 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. $885K
45,000 sh across 3 lots
Exec Oct 1 2025
Filed Oct 3 2025 · 5:30 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. $169K
9,625 sh × $17.54
Exec Sep 8 2025
Filed Sep 10 2025 · 5:30 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. $165K
11,547 sh × $14.33
Exec Aug 4 2025
Filed Aug 5 2025 · 5:30 PM ET